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Abstract
Morphogenesis is crucial to initiate physiological development and tumor invasion. Here we show that a microRNA controls
zonation morphogenesis by targeting hyaluronan receptor CD44. We have developed a novel system to study microRNA
functions by generating constructs expressing pre-miRNAs and mature miRNAs. Using this system, we have demonstrated
that expression of miR-328 reduced cell adhesion, aggregation, and migration, and regulated formation of capillary
structure. Protein analysis indicated that miR-328 repressed CD44 expression. Activities of luciferase constructs harboring
the target site in CD44, but not the one containing mutation, were repressed by miR-328. Zonation morphogenesis
appeared in cells transfected by miR-328: miR-328-transfected cells were present on the surface of zonating structures while
the control cells stayed in the middle. MiR-328-mediated CD44 actions was validated by anti-CD44 antibody, hyaluronidase,
CD44 siRNA, and CD44 expression constructs. In vivo experiments showed that CD44-silencing cells appeared as layers on
the surfaces of nodules or zonating structures. Immuno-histochemistry also exhibited CD44-negative cells on the surface
layers of normal rat livers and the internal zones of Portal veins. Our results demonstrate that miR-328 targets CD44, which is
essential in regulating zonation morphogenesis: silencing of CD44 expression is essential in sealing the zonation structures
to facilitate their extension and to inhibit complex expansion.
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Introduction
Once ignored completely or overlooked as cellular detritus,
small RNA fragments (microRNA or miRNA) that were
discovered over a decade ago recently took many by surprise
because of their widespread expression and functions [1,2,3].
miRNAs are single-stranded RNA of 18-24 nucleotides, which are
generated by sequential processing of long RNA transcripts by two
key RNase III proteins, Drosha and Dicer [4,5,6,7,8]. miRNA
functions as a guide molecule in post-transcriptional gene silencing
by partially pairing with the 39-untranslated region (UTR) of
target mRNAs, leading to translational repression [9]. miRNAs
have key roles in diverse regulatory pathways, including control of
development [10,11,12,13], cell proliferation [14,15,16], differen-
tiation [17,18,19,20,21], apoptosis [22,23], cell cycle progression
[2,24,25], immuno-response [21,26,27], protein secretion [28,29],
viral infection [30,31,32,33,34,35], tumorigenesis [36,37,38,39,40]
and many other physiological or pathological processes[21,41,42],
Recent studies indicated that microRNAs are important for tissue
morphogenesis [43,44,45,46]. However, it is not known which
microRNA(s) is the key player in this process.
In animals, miRNA genes are transcribed to generate long
primary transcripts (called pri-miRNAs), which are first cropped
by the RNase III-type enzyme Drosha to generate some hairpin
intermediates (called pre-miRNAs) in the nucleus [8,47]. Pre-
miRNAs are then exported to the cytoplasm by exportin-5, a
member of the Ran-dependent nuclear transport receptor family
[48]. Following arrival in the cytoplasm, pre-miRNAs are
subjected to another processing step by Dicer, a cytoplasmic
RNase III-type enzyme [49,50]. Although miRNAs have emerged
as key regulators of gene expression, our understanding of the
specific roles of miRNAs has been limited due to the difficulty in
tracking the functions of a particular miRNA. Exogenous miRNAs
are readily degraded by enzymes, making it impossible to obtain
stable cell lines expressing miRNAs for long-term studies in vitro or
in vivo. Although expression of a large fragment of DNA harboring
the promoter and sequence for microRNA(s) has made stable
expression possible [51], in many cases microRNAs are expressed
as a cluster, making it difficult to distinguish the function of a
particular microRNA. To allow long-term studies of miRNA
functioning in vitro and in vivo, we have developed an expression
vector harboring two copies of pre-microRNAs, a GFP tracking
unit, and an antibiotic selection marker. This allows stable
expression of high levels of the miRNA of interest in cells for
functional and complementation studies. Using this technique, we
have successfully expressed a number of miRNAs in mammalian
cells including miR-328. Using the software available [52,53,54],
we have found that miR-328 potentially targets a number of cell
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investigate the role of miR-328 in affecting cell activities by
targeting CD44 expression.
Results and Discussion
Cell Activities Affected by miR-328
To investigate the role of a microRNA in morphogenesis, it is
essential to maintain its function for a period of time. We have
generated a construct that can express the pre-microRNA of miR-
328 and GFP, with an antibiotic selection marker (Figure 1A, all
primers used in this study are listed as Supplementary Table S1).
The advantage of this construct is the stability of miRNA expression
after stable transfection. Furthermore, transfection of this construct
allows selection with neomycin, as well as rescue of positive clones
by monitoring GFP-positive colonies, or by sorting GFP-positive
cells. We have detected the expression of pre-miR-328 by RT-PCR
using RNA prepared from A431 cells stably transfected with miR-
328 (Figure 1B). The pre-miR-328 was then successfully processed
to mature miR-328, as detected by RT-PCR with primers designed
by us (Figure 1B, for diagram illustrating reaction see Supplemen-
tary Figure S1A and Table S1). The advantage of using RT-PCR
for mature microRNA analysis was the limited primer used for
annealing to template to avoid non-specific detection. In the
reaction, we only designed 15-base-pair-annealing for reverse
transcription and 12-base-pair-annealing for PCR. This should
greatly reduce non-specific interaction that can occur during
Northern hybridization. To assure that processing of the expressed
miR-328 did not interfere with the RNAi/miRNA pathways, we
analyzed a few endogenous microRNAs and observed that
transfection with miR-328 did not affect expression of endogenous
microRNAs (Figure S1B). Increased expression of mir-328 was
confirmed by real-time PCR (Figure 1C and Figure S2).
The effects of miR-328 expression on cell activities were
analyzed. A431 cells transfected with miR-328 (pooled cell line)
or a control vector expressing GFP alone were cultured on tissue
culture plates to confluence. The cultures were treated with
10 mM EDTA. Twenty min after the incubation, miR-328-
transfected cells started to detach, while vector-transfected cells
remained undetached after 25 min of incubation (Figure 2A). It
appeared that miR-328 expression might have suppressed some
adhesion molecules on the cell surface. As a concordant activity to
cell detachment is migration, wounding experiments were carried
out to test migration activity of these cells. The experiments
showed that the miR-328-transfected cells had a lower activity of
migration (Figure S3A).
To examine how cell adhesion was affected, both GFP- and
miR-328-transfected cells were incubated in the presence of
manganese or calcium for 6 hours. Little difference was observed
when manganese was present, suggesting that miR-328-promoted
cell detachment was manganese-independent but calcium-in-
volved (Figure S3B). Further experiments indicated that the effect
of calcium was concentration dependent (Figure S3C-D). The cells
were also incubated in tissue culture plates precoated without (ctrl)
or with fibronectin (FN, 50 mg/ml), hyaluronan (HA, 5 mg/ml),
and laminin (LN, 50 mg/ml) at 37uC for 2 hours followed by cell
adhesion analysis. Reduction of cell adhesion was not observed in
the plates precoated with laminin, suggesting that laminin was not
involved in this process (Figure S4A).
To examine how these two groups of cells interacted with other
extracellular matrix molecules, they were cultured in Matrigel (BD
Matrigel basement membrane matrix, Cat No. 354234) for 5, 24,
and 48 hours. Reduction of cell aggregation was observed in the
miR-328-transfected cells (Figure 2B). This effect was growth
factor-independent (Figure S4B, using BD growth factor reduced
Matrigel basement membrane matrix, Cat No. 354263). Cell
counting indicated that the formation of large complexes was not
the results of proliferation (Figure S4C). Additional matrix
molecules were also added to the Matrigel for aggregation assays.
It showed that although addition of hyaluronan promoted
aggregation of the GFP-transfected cells, expression of miR-328
was able to reduce hyaluronan’s effect on cell aggregation (Figure
S5A). When hyaluronan reached a concentration of 100 mg/ml,
cells expressing GFP alone formed branching-like structures and
this was inhibited by miR-328 expression (Figure S5B).
To test how these two groups of cells affected each other, they
were mixed in different proportions and then cultured in Matrigel.
When the cell mixture was at a ratio of 1:1, formation of
branching-like structures appeared (Figure 2C). Addition of
hyaluronan promoted this process (Figure 2D), and growth factors
were essential for the formation of branching-like structures
(Figure S5C).
Figure 1. Construction and expression of miR-328. (A) Diagram of
a construct expressing GFP, a neomycin-resistance gene, and two
hairpin structures of pre-miR-328. The bolded and capitalized letters
represent two restriction sites BglII and HindIII. The bolded lower case
sequence represents an artifact sequence inserted between two pre-
miRNAs. Six ‘‘t’’s were added to terminate transcription. A few lower
case letters represent changes of nucleotides that are not part of the
mature miR-328 but are useful for PCR purpose. (B) RT-PCR of pre-miR-
328 using RNA prepared from A431 cells stably transfected with miR-
328 and a control vector, using two primers miR-328N and miR-328C,
confirming expression of pre-miR-328. As a control, Gapdh was
amplified with two primers huGapdh131F and huGapdh380R. RT-PCR
of mature miR-328 using RNA prepared from A431 cells stably
transfected with miR-328 and a control vector, confirming proper
processing of miR-328. (C) Real-time PCR analysis confirmed expression
of mature miR-328. **, p,0.01. Error bars, SD (n=3). The end products
of real-time PCR were subjected to agarose gel electrophoresis (lower).
doi:10.1371/journal.pone.0002420.g001
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We then examined protein expression affected by miR-328
transfection. A431 cells stably transfected with miR-328 or the
vector were subjected to Western blot probed with a number of
antibodies against different adhesion molecules including E-
cadherin, P-cadherin, a-catenin, b-catenin, P-120, integrin a2,
integrin a5, and integrin b1. No significant differences were
detected between the cells transfected with miR-328 and cells
expressing GFP alone (Figure S6A). The cells were also harvested
and subjected to proteomic analysis performed by WEMB
Biochem Inc (Richmond Hill, ON). A large number of proteins
were down regulated by miR-328 transfection (Figure S7). One of
them is CD44 (Figure 3A), the major receptor of hyaluronan
[55,56]. Western blot analysis confirmed that CD44 expression
was repressed in the cells stably transfected with miR-328 (Fig 3B,
left panel). RT-PCR assays showed little difference in the cells
transfected with miR-328 as compared with the cells transfected
with the control vector (Figure 3B, right panel). This suggests that
miR-328 represses CD44 expression at the translational level. To
confirm the repression of CD44 by miR-328 expression, both miR-
328- and GFP-transfected cells were immunolabeled and analyzed
by flow cytometry. A great reduction in CD44 expression was
detected in the cells stably transfected with miR-328 as compared
with the cells transfected with GFP (Figure 3C). Immunocyto-
chemical staining further confirmed the repression of CD44
expression in cells transfected with miR-328 (Fig 3D). To confirm
that the repression of CD44 expression was a consequence of miR-
328 expression, we generated a construct expressing an antisense
RNA against miR-328. Transfection of the antisense construct
enhanced CD44 expression (Fig S6B), which did not affect the
level of mature miR-328 (Fig S6C).
To test whether CD44 expression was correlated with miR-328
levels, a number of human cell lines were analyzed for CD44
expression byWesternblots(Fig 3E)and miR-328 levels byreal-time
PCR (Fig 3F). We only detected an anti-correlation effect in three
cell lines expressing low levels of CD44 (Fig 3E, left and Fig 3F, left).
This anti-correlation effect was not observed in the cell lines
expressing high levels of CD44 (Fig 3E, right and Fig 3F, right). In
these cell lines, miR-328 may not be the major regulator of CD44
since CD44 can also be regulated by many other miRNAs.
We then analyzed 39-UTR sequence of CD44 and found three
potential targets for miR-328 (Figure 4A, GeneBank access number
NM_001001390). To directly demonstrate repression of CD44
expression by miR-328, we integrated fragments of the CD44 39-
UTR containing the miR-328 target sequences into a luciferase
report vector (pMIR-Report, Ambion; for structures and sequence
see Figure S8). Luciferase activity was significantly repressed in the
construct harboring all the potential target sequences, as
compared with the control vector harboring a non-related
fragment (Ctrl), one potential target site, or two potential target
sites (Fig 4B). This result suggests that the third sequence (CD44d,
59ttggaagctgaggagcttcag) is essential for miR-328 repression of
CD44 expression. To confirm this, we generated mutations at this
sequence (CD44d-Mut, 59ttggaagctctccacgttcag) as well as in the
potential sequence (CD44c) creating CD44c-Mut (59catggaagac-
caagctcccgag) in the luciferase reporter vector (Figure 4C).
Figure 2. Expression of miR-328 reduces cell adhesion, aggregation, and capillary formation. (A) A431 cells transfected with miR-328 or a
control vector were cultured in tissue culture plates to confluence. The cultures were treated with 10 mM EDTA for 30 min and recorded every 5 to
10 min. Cell detachment was examined under a light microscope and photographed. (B) GFP- and miR-328-transfected cells were incubated in
Matrigel for 5, 24, and 48 hours. Reduction of cell aggregation was observed in the miR-328-transfected cells. (C) GFP- and miR-328-transfected cells
were mixed in different ratios and cultured in Matrigel at 37uC for 5 or 24 hours followed by microscopic examination and photographed. Capillary
formation reached the highest level when both groups of cells were mixed in a 1:1 ratio. (D) GFP- and miR-328-transfected cells with or without mix
(GFP/miR-328 in 1:1 ratio) were cultured in Matrigel in the presence or absence of 150 mg/ml hyaluronan at 37uC for 24 hours. Addition of hyaluronan
promoted the formation of capillary structure.
doi:10.1371/journal.pone.0002420.g002
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target site abolished the effect of miR-328, while mutation of the
non-essential site produced little effect of miR-328’s repression
activity (Fig 4D). These results further confirmed that the third
sequence is essential for miR-328 repression of CD44 expression.
Although this sequence does not contain a ‘‘seed’’ sequence
perfectly matched by miR-328, it receives a high score using the
criteria we described recently [57].
To examine whether repression of CD44 levels was essential for
miR-328-induced changes in cell activities, we used anti-CD44
Figure 3. Targeting of CD44 by miR-328. (A) A431 cells transfected with miR-328 or a control vector were harvested and subjected to proteomic
analysis. Repression of CD44 expression was observed. (B) Cell lysate from miR-328- or vector-transfected A431 cells was prepared and subjected to
electrophoresis on a 10% SDS-polyacrylamide gel and analyzed by Western blotting for the expression of CD44. Repression of CD44 expression was
observed in cells transfected with miR-328 (left). Staining for actin confirmed equal loading. RNA prepared from cells stably transfected with miR-328
and the control vector was subjected to RT-PCR (right) of CD44 (primers: huCD443E1917FSacI and huCD443E2680RMluI) and Gapdh (primers:
huGapdh131F and huGapdh380R). (C) GFP- and miR-328-transfected cells were immunolabeled with anti-CD44 antibody followed by flow cytometry
analysis. Transfection with miR-328 reduced CD44 expression. (D) Immunocytometry staining was performed in A431 cells stably transfected with
miR-328/RFP or vector/GFP, followed by confocal microscopic examination of GFP (green), miR-328 (red), and CD44 expression (blue). Transfection
with miR-328 repressed CD44 expression. (E) Protein samples were prepared from a number of human cell lines and subjected to Western blot
probed with anti-CD44 antibody to analyze CD44 expression levels. Left, CD44 was expressed at relatively low levels. Right, CD44 was expressed at
high levels. (F) RNA samples were prepared from the same cell lines and analyzed for miR-328 expression by real-time PCR.
doi:10.1371/journal.pone.0002420.g003
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cells. GFP- and miR-328-transfected cells were incubated in tissue
culture plates in the presence or absence of anti-CD44 antibody at
37uC for 3 hours followed by counting of the adherent cells.
Addition of anti-CD44 antibody inhibited cell adhesion
(Figure 5A), but have little effect on cell survival, suggesting no
cell toxicity of the reagents (Figure S9A). GFP- and miR-328-
transfected cells with or without mix (in 1:1 ratio) were also
cultured in Matrigel in the presence or absence of hyaluronidase
or anti-CD44 antibody at 37uC for 24 hours followed by
microscopic examination and photographed. Addition of hyal-
uronidase or anti-CD44 antibody inhibited cell aggregation and
formation of capillary structure (Figure 5B).
To corroborate this result, we generated a siRNA construct
containing two hairpin structures complementary to CD44
sequences (Figure S9B, Left). Down regulation of CD44 was
confirmed by Western blot (Fig S9B, Right). Cell aggregation was
examined in A431 cells transfected with the siRNA construct or a
control vector expressing GFP. The experiments indicated that
transfection of CD44 siRNA promoted formation of the capillary-
like structure (Fig 5C), since the transfection efficiency was
approximately 20%, resulting in a mix of cells expressing high
Figure 4. Confirmation of miR-328 targeting CD44. (A) Computational algorithms were used to predict microRNAs that bind to a target
sequence in the 39-UTR of CD44. miR-328 was found to have several potential target sites in CD44 39-UTR. (B) COS-7 cells were co-transfected with the
miR-328 and a luciferase reporter construct, which has been engineered with different fragments of the CD44 39-UTR harbouring the target
sequences of miR-328 (Luc-CD44a, b, c, d). As a negative control, the luciferase reporter construct was engineered with a non-related fragment of
cDNA (Ctrl). Significant differences are indicated by asterisks. **, p,0.01. Error bars, SD (n=4). (C) Mutations were generated on the potential target
sequences of CD44c and CD44d (underlined). (D) COS-7 cells were co-transfected with mature miR-328 or RNA with random sequence (purchased
from GenePharma, Shanghai) serving as a control (Ctrl) and a luciferase reporter construct, which has been engineered with a fragment of the CD44
39-UTR harbouring the target sequences of miR-328 (CD44d) or a mutant construct as indicated. Significant differences are indicated by asterisks. **,
p,0.01. Error bars, SD (n=4).
doi:10.1371/journal.pone.0002420.g004
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PLoS ONE | www.plosone.org 5 June 2008 | Volume 3 | Issue 6 | e2420Figure 5. Rescue of miR-328-mediated cell activities. (A) GFP- and miR-328-transfected cells were incubated in tissue culture plates in the
presence or absence of anti-CD44 antibody at 37uC for 2 hours followed by counting of the adherent cells. Addition of anti-CD44 antibody inhibited
cell adhesion. Significant differences are indicated by asterisks. *, p,0.05. **, p,0.01. Error bars, SD (n=5). (B) GFP- and miR-328-transfected cells
without or with mix (GFP/miR-328 in 1:1 ratio) were cultured in Matrigel in the presence or absence of hyaluronidase or anti-CD44 antibody at 37uC
for 24 hours. Addition of hyaluronidase or anti-CD44 antibody inhibited cell aggregation and the formation of capillary structure. (C) A431 cells
transiently transfected with an siRNA construct against CD44 were grown in Matrigel for 24 h. Partial reduction in CD44 expression, which contained
a mix of transfected and non-transfected cells (siRNA-m) induced capillary formation compared to the GFP- or miR-328-transfected cells. The siRNA-
transfected cells were then selected by cell sorting (siRNA-s) followed by culturing in Matrigel. Reduction in cell aggregation was observed. (D) A431
cells stably transfected with miR-328 or GFP vector were transiently transfected with CD44 or a control vector. Transfection of CD44 into the miR-328-
expressing cells reversed the effect of miR-328 in reducing cell adhesion.
doi:10.1371/journal.pone.0002420.g005
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by sorting, inhibition of cell aggregation appeared in Matrigel
culture, mimicking an effect of miR-328, suggesting that the CD44-
pathway is essential for miR-328-mediated cell activities.
A431 cells stably transfected with miR-328 or GFP vector were
transfected with CD44 or a control vector. Transfection was
enriched by hygromycin selection. The cells were then cultured in
Matrigel. Transfection of CD44 into the miR-328-expressing cells
reversed the effect of miR-328 in reducing cell aggregation
(Figure 5D).
Capillary formation affected by miR-328 targeting CD44
To have a better insight of cell behaviour while CD44
expression was repressed by miR-328, Matrigel cultures of the
mixture containing both the miR-328- and the GFP-transfected
cells were subjected to confocal microscopic examination. The
control cells, which expressed GFP alone (vector/GFP), always
stayed in the middle of the tube-like structures, while the miR-328-
transfected cells (328/RFP) always surrounded the tube-like
structures (Figure 6A). Considering the presence of CD44 ligand
hyaluronan, which enhanced cell aggregation, and the presence of
E-cadherin, which mediated cell-cell interaction, we presented a
model of cell-matrix-cell interaction based on the observation of
the two groups of cell mixture (Figure 6B). Due to the repression of
CD44, the miR-328-transfected cells could not form large
complexes mediated by CD44-hyaluronan interaction. Neverthe-
less, the miR-328-transfected cells were able to interact with the
vector/GFP cells because both groups of cells expressed equal
levels of E-cadherin and, perhaps, some other adhesion molecules.
To confirm that the levels of CD44 expression affected cell
localization, cells transfected with vector/GFP were mixed with
cells transfected with vector/RFP, both of which expressed equally
high levels of CD44 (data not shown). The mixture was cultured in
Matrigel. Confocal microscopic examination indicated that both
groups of cells randomly mixed with each other and formed large
complexes (Figure 6C, vector/GFP:vector/RFP). Cells transfected
with miR-328/GFP were mixed with cells transfected with miR-
328/RFP, both of which expressed equally low levels of CD44
(data not shown), followed by Matrigel culturing. Confocal analysis
indicated that the cells mixed with each other randomly and
formed small complexes (Figure 6C, miR-328/GFP:miR-328/
RFP). Formation of tube-like structures could only be seen when
vector/GFP-transfected cells were mixed with miR-328/RFP-
transfected cells, in which the green cells stayed in the middle
while the red cells covered the surface of the tube-like structures.
To confirm the function of CD44 in the formation of tube-like
structures, the mix containing cells transfected with vector/GFP
and cells transfected with miR-328/RFP was incubated with anti-
CD44 antibody. The tube-like structures were no longer formed
(Fig 6D). Instead, both groups of cells randomly interacted with
each other, and small complexes were obtained.
To test how hyaluronan affected the formation of the tube-like
structures, the mix containing cells transfected with vector/GFP
and cells transfected with miR-328/RFP was incubated with
hyaluronidase. The tube-like structures were not formed, and only
small complexes were obtained (Figure 6D). However, the vector/
GFP-transfected cells still stayed in the middle while the red cells
covered on the surface of the small complexes, indicating that
hyaluronidase could only disrupt the formation of the tube-like
structures but could not change the location of the cells. It also
suggested that high-and-low levels of CD44 are essential for the
formation of zonating structures, implying a role of CD44 in tissue
differentiation. This is in agreement with a previous report that
CD44 mediates cell differentiation [58].
Zonating morphogenesis affected by miR-328 targeting
CD44 in vivo
We then used an in vivo model to test the effects of CD44 on cell-
cell interaction. The miR-328- and GFP-transfected A431cells
were injected subcutaneously into nude mice. Four weeks after the
injection, the mice were sacrificed and tumors were removed. The
tumors were sectioned, immunostained for CD44. Given their
epithelial origin, the melanoma A431 cells mixed well with the
stroma tissues and formed multiple small nodules. In the group
injected with miR-328-transfected cells, layers of CD44-negative
cells (blue nuclei) were detected between tumor tissues and stroma
tissues, while the CD44-positive cells were largely detected in the
internal locations of the tumors (Fig 7A). On the other hand, in the
GFP-transfected cells there were little or no CD44-negative cells in
the boundary between the tumors and the stroma tissues, since
these cells expressed high levels of CD44. It was observed that
some cells with blue nuclei were CD44-negative, which were
either mixed with stroma cells or surrounding the tumor tissues.
Some photos with large magnifications are provided to show that
the CD44-negative cells always like to push the CD44-positive
cells together, forming column-like or zonating structures (Fig 7B).
It was noted that the mouse stroma cells were mainly CD44-
negative, since the antibody (sc-9960 from Santa Cruz Biotech-
nology), which recognizes both human and mouse CD44, did not
exhibit clear staining of CD44 in the stroma cells (data not shown).
This may be the reason why A431 cells cannot form large tumors
in the skin location, as the stroma cells may be able to guild the
tumor cells to form certain smaller structures. Although the CD44-
positive cells can potentially form large tumors, as there is an
advantage for the same type of cells to assemble together for
survival, the CD44-negative stroma cells seemed not to allow this
to occur and were able to facilitate the formation of certain shape
of structures guided by the stroma cells. In the case of miR-328-
expressing cells, the levels of CD44 were low and some were
negative. Although these CD44-negative cells now served as the
guide cells for CD44-positve cells (low levels of CD44) to form
some tumor structures, they would not push the CD44-positive as
hard as the stroma cells did. As a result, the miR-328-transfected
cells were able to form relatively larger tumor nodules than the
GFP-transfected cells did. The fact that cells expressing high levels
of CD44 formed more but smaller nodules suggests that high levels
of CD44 would promote tumor metastasis. This is in agreement
with previous reports that CD44 plays a role in cancer metastasis
[59]. We also examined CD44 expression on sections of tumors
formed by astrocytoma cell line U87 and found that the surface
layers of the tumors were CD44-negative while the internal tumor
sections expressed very high levels of CD44 (Fig S9C).
We then examined whether CD44 expression is low or negative
on the surface of a naturally existing organ or tissue structure. It
was noted that the cell types on the surface and the internal region
of an organ should be the same to allow comparison. Liver is such
an ideal organ in that the cells on the surface and the internal of a
functional unit are the same, namely the hepatocytes. Rat livers
were sectioned and immunostained with anti-CD44 antibody.
CD44 expression was detected throughout the liver tissues.
However, the surface layers of cells of the tissue and the internal
zones of the Portal veins were CD44 negative (Fig 8A). It seems
that covering of CD44-positive cells with CD44-negative cells is a
requirement for tissue formation.
Our in vitro and in vivo results show that CD44-negative cells
function as a barrier for CD44-positive cells to expand: these
CD44-negative cells sealed the surface of the tissues. Only when
there were no CD44-negative cells, could the CD44-positive cells
extend. Our results explain why CD44 is always highly expressed
miR-328 in Morphogenesis
PLoS ONE | www.plosone.org 7 June 2008 | Volume 3 | Issue 6 | e2420Figure 6. Capillary formation affected by miR-328 targeting CD44. (A) GFP- and miR-328/RFP-transfected cells were mixed in a 1:1 ratio and
cultured in Matrigel at 37uC for 24 hours followed by confocal microscopic examination and photographed. Enlargement of a 536 mm-section
exhibited the presence of green cells staying in the middle of the structures, while the red cells covering on the surface of the capillary structures. (B)
A model of capillary formation affected by miR-328- and GFP-transfected cells. (C) Three types of cell mixture (1:1) were obtained including: (i) cells
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hyaluronan in the growing buds [60]. As tissues become mature,
CD44 expression decreases [61]. Each organ seems to have
particular mechanisms to form the shape of its preference, and
regulation of CD44 expression appears to be one of them. We
have thus proposed a CD44 expression model for zonating
morphogenesis (Fig 8B).
In this study, we have demonstrated that a construct harbouring
a duplicate of pre-microRNA miR-328 can be successfully
expressed and processed to mature microRNA. With this
Figure 7. Zonating morphogenesis affected by miR-328 targeting CD44 in nude mice. (A) Tumors formed by injection of cells transfected
with GFP or miR-328 were sectioned, immunostained for CD44, and photographed at 10x, 20x, and 40x magnifications. As a negative control, section
was stained with secondary antibody alone. In the miR-328 group, layers of CD44-negative cells (blue nuclei) were detected between tumor tissues
and stroma tissues. This was not evident in the GFP group, which expressed high levels of CD44. The dotted lines mark the boundary between the
tumors and stroma tissues. For those areas in which the boundary is clear, no dotted line was provided. (B) Magnified photos showing the boundary
between tumor tissues and stroma tissues. The CD44-negative cells were able to cover the surface of nodules (left), to form a zonating layers inside
the tumor tissue (center), or to cover the surface of column-like structures (right).
doi:10.1371/journal.pone.0002420.g007
transfected with vector/GFP mixed with cells transfected with vector/RFP, (ii) cells transfected with miR-328/GFP mixed with cells transfected with
miR-328/RFP, and (iii) cells transfected with vector/GFP mixed with cells transfected with miR-328/RFP. The mixture was cultured in Matrigel for
24 hours. Random cell-cell interaction was seen in mix(i) and mix(ii). (D) Cells transfected with vector/GFP were mixed with cells transfected with miR-
328/RFP with addition of anti-CD44 antibody or hyaluronidase (HAse). The mixture was cultured in Matrigel for 24 hours. Random cell-cell interaction
was seen when the mixture was incubated with anti-CD44 antibody. Presence of red cells on the surface of green cells was seen when the mixture
was treated with hyaluronidase.
doi:10.1371/journal.pone.0002420.g006
miR-328 in Morphogenesis
PLoS ONE | www.plosone.org 9 June 2008 | Volume 3 | Issue 6 | e2420approach, we have demonstrated that cells expressing miR-328
exhibited reduced adhesion and formed small complexes in
Matrigel. We also found that CD44 is the target of miR-328 in
mediating a variety of cell activities. Our research now paves the
way to understand the roles of microRNAs in an unexplored area
of development.
Materials and Methods
Materials and Cell Culture
Anti-CD44 (H3) antibody was a gift from Dr. Liu Cao. Anti-
actin and HRP-conjugated secondary antibodies were purchased
from Sigma. Cy5-conjugated secondary antibody was purchased
from Abcam. Other antibodies were purchased from Chemicon
(integrin a5), Santa Cruz Biotechology (integrin b1), BD
Transduction Laboratories (E-cadherin and P-cadherin) and
Zymed Laboratories (a-catenin and b-catenin). Matrigel (base-
ment membrane matrix and growth factor reduced) were
purchased from BD Transduction Laboratories. Luciferase assay
kits were purchased from Promega. o-nitrophenyl-b-D-galactopyr-
anoside (ONPG) was purchased from Calbiochem. Dulbecco’s
modified Eagle’s medium (DMEM), fetal bovine serum (FBS),
Hank’s balance salt solution (HBSS), trypsin/EDTA, Lipofecta-
mine, Geneticin (G418), hygromycin, oligonucleotides, T4 DNA
ligase, platinum Pfx DNA polymerase, SuperScript II reverse
transcriptase, random primer and DH5a were purchased from
Invitrogen. Restriction enzymes were purchased from New
England Biolabs. REDTaq DNA polymerase and other materials
were purchased from Sigma.
Construct Generation
A microRNA construct expressing miR-328 was designed by our
lab and the DNA synthesized by a biotech company (Top Gene
Technologies, Montreal). In brief, the pre-microRNA of miR-328
was ligated into a mammalian expression vector BluGFP that
contains a Bluescript backbone, a CMV promoter driving
expression of either green fluorescent protein (GFP) or the red
fluorescence protein (RFP), and a H1 promoter driving miR-328.
This plasmid was developed in our lab and is expected to
simultaneously express a small fragment of RNA and produce
GFP (Fig 1A). This means that every fluorescent cell expresses
mature miR-328. Using similar approach, an antisense sequence to
miR-328 was inserted in the expression vector producing an anti-
miR-328 construct. We have used this method to produce pre-
miRNAs and mature miRNAs [40].
The siRNA construct against CD44 was made by primers of
huCD44-si868p1 and huCD44-si1115p2 and was ligated with a
CMV promoter driving the green fluorescence protein (GFP) into
the mammalian expression vector (Shown as Supplementary
Figure S9B).
A luciferase reporter vector (pMir-Report; Ambion, Austin, TX)
was used to generate luciferase reporter constructs. A fragment of
the 39-untranslated region (39-UTR) of human CD44 was cloned
with two primers, huCD443E1917FSacI and huC-
D443E2884RMluI, by RT-PCR. The PCR product was digested
with SacI and MluI and inserted into a SacI- and MluI-opened
pMIR-REPORT Luciferse plasmid (Ambion), obtained a con-
struct named Luc-CD44-d (Fig S8). Three more fragments
containing continuing deletion were generated by using huC-
D443E1917FSacI combined with huCD443E2680RMluI, huC-
D443E2697RMluI, or huCD443E27884RMluI in PCR. Diges-
tion and ligation of these products led to the production of three
constructs named Luc-CD44-a, Luc-CD44-b, and Luc-CD44-c
(Fig S8). To serve as a negative control, a non-related sequence
was amplified from the coding sequence of the chicken versican
G3 domain using two primers chver10051-SpeI and chver10350-
Figure 8. Zonating morphogenesis associated with CD44 expression in rat liver. (A) Rat livers were sectioned and immunostained with
anti-CD44 antibody or the secondary antibody alone. CD44 expression was detected throughout the liver tissues. Note that the surface layers of cells
as indicated by the brackets and the internal zones of the Portal veins were CD44 negative. (B) A model showing CD44 expression patterns.
doi:10.1371/journal.pone.0002420.g008
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this fragment as it is located in the coding sequence. The amplified
PCR product was digested with SpeI and SacI, followed by
insertion into a SpeI- and SacI-open pMir-Report vector. Primers
huCD443E1917FSacI and huCD44-2884R-mu were used to
generate mutation construct CD44d-Mut. To generate mutation
construct CD44c-Mut, a two-step PCR was performed. The first
PCR used primers huCD443E1917FSacI and huCD44-2833Rmu
followed by a second PCR using primers huCD443E1917FSacI
and huCD44-2884R. The PCR product was digested with SacI
and MluI, followed by insertion into a SacI- and MluI-open pMir-
Report vector. The protein expression constructs, CD44E and
CD44H, were kind gifts from Dr. Warren Knudson [62].
The identities of all constructs were confirmed by restriction
digestion and sequencing.
To confirm expression of different constructs, control vector or
miR-328 with GFP or RFP was transfected into A431 cells by
lipofatamine 2000, and selected by G418 or hygromycin for
getting stable cell lines. Then, cells were further sorted by GFP or
RFP. Cells were maintained in DMEM with 10%FBS.
RT-PCR and RNA Analysis
For pre- and mature microRNA concentration assays, 10
7 cells
were harvested for RNA isolation. Small RNA (,200 nt) enriched
total RNA was isolated by mirVana miRNA isolation kit
(Ambion). After the adjustment of RNA concentration, 3%
agarose gel was used to check the RNA quality and amount.
1 mg RNA was used for reverse transcription with Superscript II
reverse transcriptase. The three primers, RT-328-2, PCR-328-2,
PCR-miRNA-3, were designed for the reverse transcriptase-PCR
(RT-PCR) of mature miR-328. For the pre-miR-328 assay,
random primer was used for reverse transcription, than primer
miR-328N and miR-328C were used for PCR. Gapdh (primers:
huGapdh131F and huGapdh380R) was used as a control. PCR
was carried out at the temperature of 94uC, 56uC, and 72uCo f2 5
cycles.
For the mRNA level of CD44, total RNA from 3610
6 cells was
isolated by RNeasy mini kit (Qiagen). After the adjustment of
RNA concentration, 1% agarose gel was used to check the RNA
quality and amount. 1 mg RNA was used for reverse transcription
with Superscript II reverse transcriptase. Random primer
(Invitrogen), primer huCD443E1917FSacI, and huC-
D443E2680RMluI were used for RT-PCR. Gapdh (primers:
huGapdh131F and huGapdh380R) was used as a control. PCR
was carried out at the temperature of 94uC, 56uC, and 72uCo f2 5
cycles as described previously [63].
Western Blotting
Cells were seeded onto a 6-well plate at 10
6 cells/well. Proteins
were extracted 24 hours after plating by lysing the cells in each
well in 100 ml of lysis buffer containing protease inhibitors
(150 mM NaCl, 25 mM Tris-HCl, pH 8.0, 0.5 M EDTA, 20%
Triton X-100, 8 M Urea, and 1x protease inhibitor cocktail). After
the addition of lysis buffer, the cells were scraped off and keep on
ice for 30 min. Protein concentration of lysates were measured by
Bio-Rad protein assay kit after centrifugation at 14000 rpm for
10 min. Lysates with 30 mg of protein were subjected to SDS-
PAGE for CD44 detection. Lysates with 40,80 mg of protein
were subjected to SDS-PAGE for the detection of other adhesion
molecules. The separated proteins were transferred to nitrocellu-
lose membranes followed by immunostaining with a primary
monoclonal antibody overnight at 4uC. After washing, the
membrane was incubated with appropriate HRP-conjugated
secondary antibody for 1 hour at room temperature followed by
ECL detection. After detection of protein bands, the blot was re-
probed with the primary antibody against b-actin to confirm equal
loading of samples. The monoclonal b-actin antibody (Sigma-
Aldrich) was incubated with the blot for 2 hours at room
temperature at a dilution of 1:5000. The secondary antibody used
was once again the goat anti-mouse IgG (1:2000) for 1 hour at
room temperature, followed by washes, detection with the ECL
kit, and autoradiography.
Cell Adhesion Assay
Petri-dishes were coated with 50 mg/ml laminin, fibronectin or
5 mg/ml hyaluronic acid for one hour and washed by PBS. For
ECM protein binding assay, 10
6 cells/ml in DMEM+10%FBS
were seeded at 3.5 cm coated or uncoated petri-dishes for 3 hours.
For ion adhesion assay, 10
6 cells/ml in HBSS with calcium or
manganese in different concentration were seeded at 3.5 cm
uncoated Petri dishes for 6 hours. Adhering cells were counted.
Eight different fields (100x) in three dishes were used for
calculation (n=86SD).
Cell Aggregation Assay
4610
4/cm
2 cells were seeded in BD Basic Matrixgel (basement
membrane matrix or growth factor reduced) with
DMEM+10%FBS for 24 or 48 hours. Exogenous anti-CD44,
hyaluronan or hyaluronidase were added in different experiments.
The images were captured in bright field using a light microscope
or a confocal microscope in a z-section program.
Assays of Luciferase Activity
Luciferase activity assays were performed using the Promega
Luciferase Assay System (Madison, WI) using the methods
described [54]. In brief, COS-7 cells (10
5 cells/well) were seeded
onto 12-well tissue culture plates overnight. The cultures were
changed for serum-free medium prior to transfection with different
combinations of DNA (e.g. 10 ng luciferase reporter construct
mixed with 10 ng b-Gal plasmid and 300 ng miR-328 construct).
Twenty hours after transfection, the transfection reagent was
replaced with DMEM+10%FBS culture medium, and the cultures
were maintained at 37uC for 24 hours. Cells were then harvested
using trypsin/EDTA and lysed with 150 ml 1x lysis buffer diluted
from luciferase 5x lysis buffer on ice for 30 min. After
centrifugation at 14000 rpm for 15 seconds, the supernatant was
used to measure b-Gal activity and luciferase activity in 96-well
plates in triplicate using the Promega Luciferase Assay System in
TopCount NXT (a microplate scintillation and luminescence
counter produced by Packard Instrument Company, Meriden,
CT). For the luciferase activity assay, 10 ml/well of the
supernatant was mixed with 70 ml/well of Luciferase Assay
Substrate A in black plates in a dark room followed immediately
by reading of the luciferase activity. For the b-Gal activity assay,
50 ml/well of the supernatant was mixed with 90 ml/well of
Substrate B (o-nitrophenyl-b-D-galactopyranoside or OPNG) in
transparent plates followed by incubation at 37uC for 1 hour
before reading. The experiments were repeated four times.
Luciferase activities were normalized against b-Gal activity.
Flow Cytometry Analysis and Immunocytochemistry
For flow cytometry detection, 10
5 cells/well were seeded into
12-well plates for overnight culture then harvested by 10 mM
EDTA in PBS. For immunocytochemistry, control cells with GFP
and miR-328 transfected cells with RFP were mixed together in a
ratio of 1:1 and seeded into 12-well plates with cover slices in a
concentration of 5610
4 cells/well. The cells were fixed in 3.7%
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1% BSA in PBS. They were then immunostained with primary
antibody diluted in blocking solution at room temperature for 1
hour. 2 mg/ml anti-CD44 and 1 mg/ml cy5-conjugated secondary
antibody in PBS with 1% BSA were used for staining. The cells
were rinsed three times with PBS and incubated with secondary
antibody coupled to cy5 for 45 min. Slides were then rinsed three
times with PBS before mounting, and visualized using a Zeiss
confocal microscope using methods described [64].
Tumorigenicity Assays in Nude Mice and
Immunohistochemistry
The methods have been described by us previously [65,66]. In
brief, six-week-old nude mice strain Balb/c were injected with
miR-328- and GFP-transfected U87 cell lines (5610
6 cells in 100
PBS). Tumors were measured weekly thereafter. Tumor volume
(V) was measured using a caliper by determining the length (L) and
width (W), where V=(L6W
2)/2. Four weeks after injection,
tumors were removed for further analysis. To confirm the effect of
miR-328, we used a different cell line for tumorigenesis assay each
time. Tumors were fixed in 10% buffered formalin, processed, and
embedded in paraffin. Immunohistochemistry was performed on
5 mm paraffin sections mounted on charged slides. The sections
were stained with hematoxylin and eosin (H&E) and immuno-
stained with either anti-CD44 antibody or secondary antibody as a
control using the ABC and DAB Kits from Vector Laboratories
Inc (Burlingame, CA).
Statistical Analysis
The results (mean values6SE) of all the experiments were
subjected to statistical analysis by t-test. The level of significance
was set at p,0.05.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0002420.s001 (0.04 MB
DOC)
Figure S1 A, Diagram of the procedure of RT-PCR of mature
microRNA miR-328. The mRNA was isolated with mirVana
miRNA Isolation Kit (Ambion, Austin, TX). RT-PCR was
performed using Superscript II Reverse Transcriptase (Invitrogen).
PCR was carried out at the temperature of 94uC, 56uC, and 72uC
for 25 cycles. B, RT-PCR of mature miR-328, miR-378, miR-17-
3p, and miR-17-5p using RNA prepared from A431 cells stably
transfected with miR-328 and a control vector, confirming that
processing of other microRNAs was not affected by miR-328
transfection.
Found at: doi:10.1371/journal.pone.0002420.s002 (0.12 MB PPT)
Figure S2 A, The melting curves in real-time PCR experiments
reveal undetectable contamination, mispriming, and primer-dimer
artifacts of all samples indicated on the left of the curves. B, Real-
time PCR curves of mature miR-328 from RNAs isolated from
miR-328- and GFP vector-transfected cells. Real-time PCR was
carried out according to the manufacturer’s instructions (Qiagen,
miScript Reverse Transcription Kit, cat #218060; miScript
Primer Assay, cat #218411; miScript SYBR Green PCR Kit,
cat #218073).
Found at: doi:10.1371/journal.pone.0002420.s003 (0.23 MB PPT)
Figure S3 A, GFP- and miR-328-transfected cells were cultured
on tissue culture plates to confluence. The cultures were wounded
by a micro-tip. Migration of cells to the wounding areas was
examined under a light microscope and photographed. [Cell
migration assay: Wound healing experiments were used to
examine cell migration. Cells (36106) were seeded on 3.5 cm
culture dishes in DMEM supplemented with 10% FBS. Twenty-
four hours after cell inoculation, sub-confluent monolayers were
wounded linearly by scraping with p1000 pipette tips, washed to
remove cell debris and refilled with fresh media. The images were
captured at the beginning and 15 hours later with a phase-contrast
microscope.] B, GFP- and miR-328-transfected cells were
incubated in Petri dishes in the presence of HBSS with manganese
(Mn) or calcium (Ca) for 6 hours. C, GFP- and miR-328-
transfected cells were incubated on Petri dishes in the presence
of 0.2, 0.5, and 1.0 mM CaCl2 for 6 hours. Cell adhesion was
analyzed by counting the cells that adhered to plates. miR-328-
transfected cells exhibited lower rates of adhesion than the GFP-
transfected cells. Error bars, SD (n=8). D, typical micrographs of
cell attachment are shown.
Found at: doi:10.1371/journal.pone.0002420.s004 (2.64 MB PPT)
Figure S4 A, Expression of miR-328 reduces cell adhesion.
GFP- and miR-328-transfected cells were incubated in Petri dishes
precoated without (Ctrl) or with fibronectin (FN, 50 mg/ml),
hyaluronan (HA, 5 mg/ml), and laminin (LN, 50 mg/ml). The
cultures were maintained at 37uC for 3 hours in culture medium
followed by microscopic examination. Adherent cells were
counted. Reduction of cell adhesion was observed in the miR-
328-transfected cells. B, FP- and miR-328-transfected cells were
incubated in Matrigel with or without growth factors. C, cell
number was counted to determine rates of proliferation.
[Proliferation assay: 26105 /well of vector- and miR-328-
transfected A431 cells were seeded to 6-well plastic tissue culture
plates in DMEM containing 10% FBS, and incubated for different
time periods. The cultures were trypsinised and concentrated to a
volume of 100 &#xF06D;l for counting by hemocytometer
(n=36S.D.).] m
Found at: doi:10.1371/journal.pone.0002420.s005 (1.12 MB PPT)
Figure S5 A, GFP- and miR-328-transfected cells were
incubated in Matrigel without (Ctrl) or with hyaluronan (HA,
50 ng/ml), fibronectin (FN, 50 ng/ml), and laminin (LN, 50 ng/
ml). The cultures were maintained at 37uC for 24 hours followed
by microscopic examination and photographed. Reduction of cell
aggregation was observed in the miR-328-transfected cells. B, The
cells were also incubated in Matrigel with the addition of 0, 25, 50,
and 100 mg/ml hyaluronan for 24 hours. Addition of hyaluronan
promoted tube-like structure formation. C, GFP- and miR-328-
transfected cells were mixed in a 1:1 ratio. The mixed cells were
incubated in Matrigel with or without growth factors (GF) at 37uC
for 24 hours followed by microscopic examination and photo-
graphed. Presence of growth factors promoted the formation of
tube-like structures. m
Found at: doi:10.1371/journal.pone.0002420.s006 (7.07 MB PPT)
Figure S6 A, GFP- and miR-328-transfected cells were cultured
on tissue culture plates to confluence. Cell lysate was prepared and
subjected to Western blotting probing with antibodies against
different adhesion molecules as indicated. Little difference was
detected. B, GFP-, miR-328-, and anti-miR-328 (antisense against
miR-328)-transfected cells were cultured on tissue culture plates to
confluence. Cell lysate was prepared and subjected to Western
blotting probing with antibodies against CD44 or actin. C, RNA
samples were also prepared for RT-PCR amplifying pre-miR-328
and mature miR-328.
Found at: doi:10.1371/journal.pone.0002420.s007 (0.99 MB PPT)
Figure S7 Proteomic results. GFP- and miR-328-transfected
cells were cultured on tissue culture plates to confluence. Cell
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number of proteins were detected to be down-regulated (A) and
up-regulated (B) by miR-328-transfection.
Found at: doi:10.1371/journal.pone.0002420.s008 (2.30 MB PPT)
Figure S8 Luciferase report constructs for CD44. Fragments of
CD44 3’UTR were inserted into the luciferase report vector
pMiR-Report producing a constructs named Luc-CD44a, Luc-
CD44b, Luc-CD44c, and Luc-CD44d . The potential mir-328
target sequences were labelled in blue. A control sequence (Ctrl)
was obtained from the G3 domain of chicken versican.
Found at: doi:10.1371/journal.pone.0002420.s009 (0.04 MB PPT)
Figure S9 A, GFP- and miR-328-transfected cells were cultured
in the presence or absence of anti-CD44 antibody or hyaluron-
idase at 37uC for 48 hours followed by viability assays using an
MTT assay kit. (Toxicity assay: Cells were seeded at a
concentration of 26103 cells/well in 96-well plate without or
with anti-CD44 antibody or hyaluronidase for 48 hours. MTT
assay was used for detecting cell viability.) B, siRNA construct for
CD44 (left). siRNA-mediated silencing of CD44 was examined by
Western blot probed with anti-CD44 antibody (right). C, Tumor
tissue stained with CD44. Tumors formed by astrocytoma cells
U87 were subjected to immunohistochemistry with anti-CD44
antibody. CD44-negative layers as indicated by the brackets were
detected between the tumor tissue and the stroma tissue.
Found at: doi:10.1371/journal.pone.0002420.s010 (1.13 MB PPT)
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